about
Microglia P2Y₆ receptors mediate nitric oxide release and astrocyte apoptosisP2Y6-deficiency increases micturition frequency and attenuates sustained contractility of the urinary bladder in mice.Activation of P2Y6 receptors increases the voiding frequency in anaesthetized rats by releasing ATP from the bladder urothelium.Western Blotting Inaccuracies with Unverified Antibodies: Need for a Western Blotting Minimal Reporting Standard (WBMRS).P2Y receptors in Alzheimer's disease.The PRKAA1/AMPKα1 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMMLGeneration and Characterization of Specific Antibodies to the Murine and Human Ectonucleotidase NTPDase8.Antibodies for immunolabeling by light and electron microscopy: not for the faint hearted.Selectivity of pharmacological tools: implications for use in cell physiology. A review in the theme: Cell signaling: proteins, pathways and mechanisms.Therapeutic targets for overactive bladder other than smooth muscle.Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.Antibodies That Work Again and Again and Again.Human urothelial cell lines as potential models for studying cannabinoid and excitatory receptor interactions in the urinary bladder.P2Y6 Receptor Antagonist MRS2578 Inhibits Neutrophil Activation and Aggregated Neutrophil Extracellular Trap Formation Induced by Gout-Associated Monosodium Urate Crystals.P2Y₆ receptor inhibition perturbs CCL2-evoked signalling in human monocytic and peripheral blood mononuclear cellsRat β₃-adrenoceptor protein expression: antibody validation and distribution in rat gastrointestinal and urogenital tissues.
P2860
Q28393984-4267DC7A-1A06-46B8-9D4E-960F20B695E4Q33677866-B5F820DB-D11E-4103-ABE7-27F614720070Q33929761-7F030340-FFF1-4906-80B0-CD0CD9B556C7Q34490107-D1452323-9FD3-4DDF-828C-8EE93C5E8585Q34860664-3F347D51-D296-48EB-9237-C8C7E236CBC7Q36111614-57621A3E-00D6-4574-9221-07863B329641Q37686003-1CD77DE4-0126-4D72-AA0F-17B7CA640CBEQ38242657-7D851DE8-EB4E-43EC-8042-F6BD4ECFDB6AQ38336214-4439DA59-9639-4990-8D46-0C338A2437D2Q38364035-1EF250C6-3C23-413D-9B37-A6CF08DD7395Q38830526-A3280030-FB1F-4AB7-A79A-140A38891656Q38968520-9706145B-FC91-46EF-AE1A-580FD4ED7749Q39013400-30130CC5-5827-4FAF-8C55-00EA8B4E3555Q40428922-221B6FB1-F48F-4C7D-8437-366CB734CC8DQ42101139-72AC12AA-9744-47AE-94AE-84CF71EFDB99Q45073575-31123DC0-167D-452A-B3BA-9EDB1C585A67
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lack of specificity shown by P2Y6 receptor antibodies.
@en
Lack of specificity shown by P2Y6 receptor antibodies.
@nl
type
label
Lack of specificity shown by P2Y6 receptor antibodies.
@en
Lack of specificity shown by P2Y6 receptor antibodies.
@nl
prefLabel
Lack of specificity shown by P2Y6 receptor antibodies.
@en
Lack of specificity shown by P2Y6 receptor antibodies.
@nl
P2860
P1476
Lack of specificity shown by P2Y6 receptor antibodies
@en
P2093
P2860
P2888
P304
P356
10.1007/S00210-013-0894-8
P577
2013-06-22T00:00:00Z